CALANDRA BUONAURA, Sebastiano
 Distribuzione geografica
Continente #
NA - Nord America 19.194
AS - Asia 8.879
EU - Europa 7.573
SA - Sud America 1.270
AF - Africa 178
Continente sconosciuto - Info sul continente non disponibili 167
OC - Oceania 16
Totale 37.277
Nazione #
US - Stati Uniti d'America 18.867
SG - Singapore 3.238
GB - Regno Unito 2.553
CN - Cina 2.190
IT - Italia 1.668
HK - Hong Kong 982
BR - Brasile 970
VN - Vietnam 821
SE - Svezia 773
DE - Germania 562
BD - Bangladesh 450
FI - Finlandia 371
FR - Francia 348
UA - Ucraina 342
RU - Federazione Russa 329
KR - Corea 221
TR - Turchia 215
IN - India 205
BG - Bulgaria 141
CA - Canada 141
ID - Indonesia 117
NL - Olanda 111
AR - Argentina 96
MX - Messico 85
IE - Irlanda 72
IQ - Iraq 68
JP - Giappone 54
BE - Belgio 52
PK - Pakistan 50
ZA - Sudafrica 50
PL - Polonia 47
CO - Colombia 42
EC - Ecuador 41
AE - Emirati Arabi Uniti 39
CL - Cile 39
ES - Italia 39
CZ - Repubblica Ceca 27
AT - Austria 26
SA - Arabia Saudita 23
VE - Venezuela 23
KE - Kenya 22
MA - Marocco 21
EG - Egitto 20
TN - Tunisia 20
UZ - Uzbekistan 20
MY - Malesia 19
PY - Paraguay 18
BZ - Belize 17
CH - Svizzera 17
DZ - Algeria 17
IR - Iran 17
JM - Giamaica 16
LT - Lituania 16
PE - Perù 16
UY - Uruguay 16
AU - Australia 14
BA - Bosnia-Erzegovina 14
JO - Giordania 14
PH - Filippine 14
CR - Costa Rica 12
PT - Portogallo 12
TW - Taiwan 12
OM - Oman 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
NP - Nepal 10
TH - Thailandia 10
TT - Trinidad e Tobago 10
RO - Romania 9
BH - Bahrain 8
BO - Bolivia 8
DO - Repubblica Dominicana 8
EU - Europa 8
IL - Israele 8
GT - Guatemala 7
AL - Albania 6
ET - Etiopia 6
HN - Honduras 6
KG - Kirghizistan 6
KW - Kuwait 6
PR - Porto Rico 6
SK - Slovacchia (Repubblica Slovacca) 6
DK - Danimarca 5
HU - Ungheria 5
LB - Libano 5
NI - Nicaragua 5
SV - El Salvador 5
GR - Grecia 4
HR - Croazia 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
EE - Estonia 3
GE - Georgia 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
SC - Seychelles 3
Totale 37.079
Città #
Singapore 2.115
Ashburn 1.934
Southend 1.865
Fairfield 1.752
Santa Clara 1.679
Woodbridge 1.212
San Jose 1.051
Houston 1.008
Hong Kong 962
Hefei 769
Chandler 751
Jacksonville 746
Seattle 701
Wilmington 618
Ann Arbor 616
Cambridge 560
Nyköping 458
Dearborn 445
Council Bluffs 443
London 373
Beijing 342
Los Angeles 285
Ho Chi Minh City 272
Helsinki 253
Seoul 218
The Dalles 216
Milan 212
Modena 209
New York 207
Chicago 204
Hanoi 192
San Diego 153
Princeton 148
Columbus 147
Sofia 134
Reading 129
Buffalo 124
Lauterbourg 118
Rome 118
Eugene 115
Dallas 104
Moscow 104
Shanghai 97
São Paulo 91
Des Moines 90
Izmir 88
Grafing 82
Salt Lake City 79
Jakarta 78
Dublin 70
Naples 60
Munich 59
Da Nang 56
Boardman 55
Orem 55
Falls Church 49
Atlanta 45
Rio de Janeiro 45
Brussels 41
Tokyo 41
Bologna 38
Bremen 38
Elk Grove Village 38
Phoenix 38
Tampa 38
Toronto 37
Frankfurt am Main 34
Warsaw 33
Brooklyn 28
Mexico City 28
Montreal 28
Redwood City 28
Belo Horizonte 27
Norwalk 27
Guangzhou 26
Nuremberg 26
Santiago 26
Chennai 25
Turin 24
Baghdad 23
Nanjing 23
Detroit 22
Haiphong 22
Johannesburg 22
North Bergen 22
Philadelphia 22
San Mateo 22
Manchester 21
San Francisco 21
Boston 20
Brno 20
Denver 20
Kent 20
Miano 20
Newark 20
St Louis 20
Palermo 19
Poplar 19
Kunming 18
Miami 18
Totale 26.264
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.208
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 534
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease 410
A 'de novo' point mutation of the low-density lipoprotein receptor gene in an Italian subject with primary hypercholesterolemia 397
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 386
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia 378
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia 373
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 372
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy 371
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 368
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G > C mutation in ABCA1 gene 361
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 360
A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region 359
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5) 358
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 355
Altered mRNA splicing in lipoprotein disorders 355
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia. 351
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 348
Adaptor protein ARH is recruited to the plasma membrane by low density lipoprotein (LDL) binding and modulates endocytosis of the LDL/LDL receptor complex in hepatocytes 335
An apparent inconsistency in parent to offspring transmission ofpoint mutations of LDLR gene in familial hypercholesterolemia 335
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. 332
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 331
MOLECULAR CHARACTERIZATION OF TWO PATIENTS WITH SEVERE LCAT DEFICIENCY 327
Absence of apolipoprotein B-48 in the chick, Gallus domesticus 327
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia 327
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. 326
Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol. 323
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 321
Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. 318
A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. 317
APOA5 and trigliceride metabolism, lesson from human APOA5 deficiency. 316
Molecular diagnosis of hypobetalipoproteinemia: an ENID Review 316
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. 314
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 308
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients 307
Hypobetalipoproteinemia with an apparently recessive inheritance due to a de novo mutation of apolipoprotein B 306
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 306
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 305
Functional lecithin: Cholesterol acyltransferase Is not required for efficient atheroprotection in humans 303
Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. 301
Separation of the isoprotein forms of apoprotein A-I of rat, rabbit and human HDL by combined isoelectrofocusing and SDS-polyacrylamide gel electrophoresis. 297
Preemptive liver transplantation in a child with familial hypercholesterolemia 297
Denaturing high-performance liquid chromatography in the detection of ABCA1 gene mutations in familial HDL deficiency 296
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 294
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): A phenotypic comparison 294
Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. 292
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 292
Severe HDL deficiency due to novel defects in the ABCA1 transporter 289
Rearrangements of the ABCC6 gene in Italian patients with PXE 289
A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene 289
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia 288
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian Patients: Identification and structural modeling of novel mutations 288
Effect of the desulfation of heparin on its anticoagulant and anti-proliferative activity 287
Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia 282
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders 280
Isoforms of rat apolipoprotein A-I isolated from the lipoproteins of hepatic Golgi apparatus and plasma. 279
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 279
Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study 277
Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia 276
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 276
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene 272
Characterization of three mutations of the low density lipoprotein receptor gene in Italian patients with familial hypercholesterolemia. 271
Cholesterol synthesis in isolated rat hepatocytes: effect of homologous and heterologous serum lipoproteins. 271
Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick 270
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 270
Effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome 268
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia 266
Pravastatin in heterozygous familial hypercholesterolemia: low-density lipoprotein (LDL) cholesterol-lowering effect and LDL receptor activity on skin fibroblastS. 264
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B 261
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. 259
A large deletion in the LDL receptor gene--the cause of familial hypercholesterolemia in three Italian families: a study that dates back to the 17th century (FH-Pavia 257
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 256
Characterization of Three Kindreds with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 253
Plasma lipoproteins in rats with experimental biliary obstruction. II. An ultrastructural study. 252
Severe hypertriglyceridemia in a newborn with monogenic lipoprotein lipase deficiency: an unconventional therapeutic approach with exchange transfusion. 252
Changes of the main isoform of human apolipoprotein A-I following incubation of plasma. 249
Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. 246
β-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia 244
Partial duplication of the EGF precursor homology domain of the LDL receptor protein causing familial hypercholesterolemia (FH-Salerno) 242
Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney 241
Heavy metals and experimental atherosclerosis. Effect of lead intoxication on rabbit plasma lipoproteins. 241
Duplication of exons 13, 14 and 15 of the LDL-receptor gene in a patients with heterozygous familial hypercholesterolemia 240
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside: hepatic synthesis of lipoproteins and apolipoproteins. 239
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 239
Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage 238
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 238
Genetics and molecular biology: proprotein convertase subtilisin/kexin type 9 and LDL receptor--an intriguing story. 238
Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside. 237
The molecular basis of lecithin: Cholesterol acyltransferase deficiency syndromes: A comprehensive study of molecular and biochemical findings in 13 unrelated Italian families 231
In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia 231
Synthesis and secretion of apolipoprotein A-I by chick skin. 229
Isolation of a cDNA clone for chick intestinal apolipoprotein AI (Apo-AI) and its use for detecting apo-AI mRNA expression in several chick tissues. 226
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). 226
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia 224
Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome 223
Plasma lecithin: cholesterol acyltransferase activity in liver disease. 223
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside. Plasma and urinary lipoproteins 221
Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver 220
A man with low cholesterol and weakness of the lower limbs. 219
The complete sequence of chick apolipoprotein AI mRNA and its expression in the developing chick 218
Totale 30.151
Categoria #
all - tutte 143.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.261 0 0 317 155 55 210 204 103 284 178 494 261
2022/20232.390 258 267 163 197 285 383 37 213 324 53 99 111
2023/20241.564 66 78 144 141 292 162 150 162 56 90 40 183
2024/20256.147 196 52 118 406 1.129 968 592 340 534 191 712 909
2025/202611.918 788 548 973 1.144 1.925 810 1.520 595 993 1.195 758 669
2026/20271.429 528 675 226 0 0 0 0 0 0 0 0 0
Totale 37.277